Efficacy and Safety of a Chinese Herbal Medicine Formula (RCM-104) in the Management of Simple Obesity: A Randomized, Placebo-Controlled Clinical Trial

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2012 May 3

PMID 22550541

Citations 21

Authors

George Binh Lenon

Kang Xiao Li

Yung-Hsien Chang

Angela Weihong Yang

Clifford Da Costa

Chun Guang Li

Marc Cohen

Neil Mann

Charlie C L Xue

Affiliations

Soon will be listed here.

Abstract

Objective. This study was to evaluate the efficacy and safety of a Chinese herbal medicine formula (RCM-104) for the management of simple obesity. Method. Obese subjects aged between 18 and 60 years were selected for 12-week, double-blind, randomized, placebo-controlled trial. Subjects were randomly assigned to take 4 capsules of either the RCM-104 formula (n = 59) or placebo (n = 58), 3 times daily for 12 weeks. Measures of BW, BMI and WC, HC, WHR and BF composition were assessed at baseline and once every four weeks during the 12 week treatment period. Results. Of the 117 subjects randomised, 92 were included in the ITT analysis. The weight, BMI and BF in RCM-104 group were reduced by 1.5 kg, 0.6 kg/m(2) and 0.9% and those in the placebo group were increased by 0.5 kg, 0.2 kg/m(2) and 0.1% respectively. There were significant differences in BW and BMI (P < 0.05) between the two groups. Eleven items of the WLQOQ were significantly improved in the RCM-104 group while only 2 items were significantly improved in the placebo group. Adverse events were minor in both groups. Conclusion. RCM-104 treatment appears to be well tolerated and beneficial in reducing BW and BMI in obese subjects.

Citing Articles

Methodological insights into intervention and outcomes in randomised controlled trials of herbal medicine for obesity: a scoping review.

Chan J, Lau M, Muhamad Rosli S, Mustapha Kamal S, Wan Seman W, Ali N Ther Adv Chronic Dis. 2025; 16:20406223241310206.

PMID: 39917276 PMC: 11795625. DOI: 10.1177/20406223241310206.

Inhibitory effect of stinging nettle ( L.) extract on body weight gain in rats on a high-fat diet.

Kacak K, Yaman T, Uyar A, Ufuk Komuroglu A Prz Gastroenterol. 2024; 19(1):23-32.

PMID: 38571539 PMC: 10985764. DOI: 10.5114/pg.2023.130142.

Efficacy and safety of traditional chinese medicine treatment for overweight and obese individuals: A systematic review and meta-analysis.

Wen Z, Zhang Q, Zhang L, Shen M, Huang Y, Zhao L Front Pharmacol. 2022; 13:964495.

PMID: 36278196 PMC: 9581128. DOI: 10.3389/fphar.2022.964495.

Tackling Dyslipidemia in Obesity from a Nanotechnology Perspective.

Trandafir L, Dodi G, Frasinariu O, Luca A, Butnariu L, Tarca E Nutrients. 2022; 14(18).

PMID: 36145147 PMC: 9504099. DOI: 10.3390/nu14183774.

Effect of soybean milk fermented with HFY01 isolated from yak yogurt on weight loss and lipid reduction in mice with obesity induced by a high-fat diet.

Li C, Liu H, Yang J, Mu J, Wang R, Zhao X RSC Adv. 2022; 10(56):34276-34289.

PMID: 35519026 PMC: 9056763. DOI: 10.1039/d0ra06977a.

References

Choan E, Segal R, Jonker D, Malone S, Reaume N, Eapen L . A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urol Oncol. 2005; 23(2):108-13. DOI: 10.1016/j.urolonc.2004.10.008. View

Boozer C, Nasser J, Heymsfield S, Wang V, Chen G, Solomon J . An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord. 2001; 25(3):316-24. DOI: 10.1038/sj.ijo.0801539. View

Bray G, Popkin B . Dietary fat intake does affect obesity!. Am J Clin Nutr. 1998; 68(6):1157-73. DOI: 10.1093/ajcn/68.6.1157. View

Baskin M, Ard J, Franklin F, Allison D . Prevalence of obesity in the United States. Obes Rev. 2005; 6(1):5-7. DOI: 10.1111/j.1467-789X.2005.00165.x. View

Blissmer B, Riebe D, Dye G, Ruggiero L, Greene G, Caldwell M . Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: intervention and 24 month follow-up effects. Health Qual Life Outcomes. 2006; 4:43. PMC: 1553435. DOI: 10.1186/1477-7525-4-43. View

Sun F, Yu J . The effect of a special herbal tea on obesity and anovulation in androgen-sterilized rats. Proc Soc Exp Biol Med. 2000; 223(3):295-301. DOI: 10.1177/153537020022300312. View

Dulloo A, Seydoux J, Girardier L, Chantre P, Vandermander J . Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord. 2000; 24(2):252-8. DOI: 10.1038/sj.ijo.0801101. View

Ludbrook J . Multiple comparison procedures updated. Clin Exp Pharmacol Physiol. 1999; 25(12):1032-7. DOI: 10.1111/j.1440-1681.1998.tb02179.x. View

Voss K, Brennecke L . Toxicological and hematological effects of sicklepod (Cassia obtusifolia) seeds in Sprague-Dawley rats: a subchronic feeding study. Toxicon. 1991; 29(11):1329-36. DOI: 10.1016/0041-0101(91)90119-c. View

10.

Sun H . Relation between treatment course and therapeutic effects of acupuncture for female obesity of different types. J Tradit Chin Med. 2009; 28(4):258-61. DOI: 10.1016/s0254-6272(09)60005-4. View

11.

Coffey C, Steiner D, Baker B, Allison D . A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. Int J Obes Relat Metab Disord. 2004; 28(11):1411-9. DOI: 10.1038/sj.ijo.0802784. View

12.

Chantre P, Lairon D . Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine. 2002; 9(1):3-8. DOI: 10.1078/0944-7113-00078. View

13.

Talpur N, Echard B, Manohar V, Preuss H . Influence of a combination of herbs on appetite suppression and weight loss in rats. Diabetes Obes Metab. 2001; 3(3):181-5. DOI: 10.1046/j.1463-1326.2001.00126.x. View

14.

Ballinger A, Peikin S . Orlistat: its current status as an anti-obesity drug. Eur J Pharmacol. 2002; 440(2-3):109-17. DOI: 10.1016/s0014-2999(02)01422-x. View

15.

Thorburn A . Prevalence of obesity in Australia. Obes Rev. 2005; 6(3):187-9. DOI: 10.1111/j.1467-789X.2005.00187.x. View

16.

James W, Caterson I, Coutinho W, Finer N, Van Gaal L, Maggioni A . Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010; 363(10):905-17. DOI: 10.1056/NEJMoa1003114. View

17.

Ora J, Laveneziana P, Wadell K, Preston M, Webb K, ODonnell D . Effect of obesity on respiratory mechanics during rest and exercise in COPD. J Appl Physiol (1985). 2011; 111(1):10-9. DOI: 10.1152/japplphysiol.01131.2010. View

18.

Ohno K, Chung H, Maruyama I, Tani T . Bofutsushosan, a traditional Chinese formulation, prevents intimal thickening and vascular smooth muscle cell proliferation induced by balloon endothelial denudation in rats. Biol Pharm Bull. 2005; 28(11):2162-5. DOI: 10.1248/bpb.28.2162. View

19.

Hioki C, Yoshimoto K, Yoshida T . Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance. Clin Exp Pharmacol Physiol. 2004; 31(9):614-9. DOI: 10.1111/j.1440-1681.2004.04056.x. View

20.

Heber D . Herbal preparations for obesity: are they useful?. Prim Care. 2003; 30(2):441-63. DOI: 10.1016/s0095-4543(03)00015-0. View